RedHill Biopharma (RDHL) said late Thursday it received a notice from Nasdaq for noncompliance with a listing rule.
The company failed to meet the minimum $2.5 million stockholders' equity requirement, based on its annual report filed April 10.
RedHill said it has until May 30 to submit a plan to regain compliance, the company said.
Shares of RedHill were down nearly 2% in after-hours trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.